FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134605973> ?p ?o ?g. }

• W3134605973 abstract "Abstract There is an urgent need to develop effective interventions resistant to the evolving variants of SARS-CoV-2. Nanobodies (Nbs) are stable and cost-effective agents that can be delivered by novel aerosolization route to treat SARS-CoV-2 infections efficiently. However, it remains unknown if they possess broadly neutralizing activities against the prevalent circulating strains. We found that potent neutralizing Nbs are highly resistant to the convergent variants of concern that evade a large panel of neutralizing antibodies (Abs) and significantly reduce the activities of convalescent or vaccine-elicited sera. Subsequent determination of 9 high-resolution structures involving 6 potent neutralizing Nbs by cryoelectron microscopy reveals conserved and novel epitopes on virus spike inaccessible to Abs. Systematic structural comparison of neutralizing Abs and Nbs provides critical insights into how Nbs uniquely target the spike to achieve high-affinity and broadly neutralizing activity against the evolving virus. Our study will inform the rational design of novel pan-coronavirus vaccines and therapeutics." @default.
• W3134605973 created "2021-03-15" @default.
• W3134605973 creator A5002785674 @default.
• W3134605973 creator A5020529918 @default.
• W3134605973 creator A5022162844 @default.
• W3134605973 creator A5022470629 @default.
• W3134605973 creator A5034596312 @default.
• W3134605973 creator A5038928062 @default.
• W3134605973 creator A5041538214 @default.
• W3134605973 creator A5053607742 @default.
• W3134605973 creator A5059482122 @default.
• W3134605973 creator A5062544882 @default.
• W3134605973 creator A5063864987 @default.
• W3134605973 creator A5075596275 @default.
• W3134605973 creator A5076643205 @default.
• W3134605973 creator A5082620489 @default.
• W3134605973 date "2021-03-10" @default.
• W3134605973 modified "2023-09-28" @default.
• W3134605973 title "Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes" @default.
• W3134605973 cites W1970379663 @default.
• W3134605973 cites W2000106654 @default.
• W3134605973 cites W2094956070 @default.
• W3134605973 cites W2253581743 @default.
• W3134605973 cites W2316123699 @default.
• W3134605973 cites W2432427150 @default.
• W3134605973 cites W2587625522 @default.
• W3134605973 cites W2883609523 @default.
• W3134605973 cites W2899714098 @default.
• W3134605973 cites W2997234557 @default.
• W3134605973 cites W3014656992 @default.
• W3134605973 cites W3035950190 @default.
• W3134605973 cites W3036607916 @default.
• W3134605973 cites W3041222256 @default.
• W3134605973 cites W3041493976 @default.
• W3134605973 cites W3042332408 @default.
• W3134605973 cites W3042825269 @default.
• W3134605973 cites W3044914269 @default.
• W3134605973 cites W3048714202 @default.
• W3134605973 cites W3087128437 @default.
• W3134605973 cites W3093842248 @default.
• W3134605973 cites W3094211096 @default.
• W3134605973 cites W3094968263 @default.
• W3134605973 cites W3095224136 @default.
• W3134605973 cites W3096658347 @default.
• W3134605973 cites W3096751000 @default.
• W3134605973 cites W3096816634 @default.
• W3134605973 cites W3098400443 @default.
• W3134605973 cites W3101009701 @default.
• W3134605973 cites W3103843063 @default.
• W3134605973 cites W3104722250 @default.
• W3134605973 cites W3105259316 @default.
• W3134605973 cites W3106351511 @default.
• W3134605973 cites W3108495343 @default.
• W3134605973 cites W3111431752 @default.
• W3134605973 cites W3118443299 @default.
• W3134605973 cites W3119147846 @default.
• W3134605973 cites W3123160442 @default.
• W3134605973 cites W3123429991 @default.
• W3134605973 cites W3123836702 @default.
• W3134605973 cites W3124782715 @default.
• W3134605973 cites W3125568337 @default.
• W3134605973 cites W3126729284 @default.
• W3134605973 cites W3127277789 @default.
• W3134605973 cites W3127852352 @default.
• W3134605973 cites W3130039396 @default.
• W3134605973 cites W3130842863 @default.
• W3134605973 cites W3130993230 @default.
• W3134605973 cites W3131016929 @default.
• W3134605973 cites W3134208712 @default.
• W3134605973 cites W3158223263 @default.
• W3134605973 doi "https://doi.org/10.1101/2021.03.09.434592" @default.
• W3134605973 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7987009" @default.
• W3134605973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33758850" @default.
• W3134605973 hasPublicationYear "2021" @default.
• W3134605973 type Work @default.
• W3134605973 sameAs 3134605973 @default.
• W3134605973 citedByCount "11" @default.
• W3134605973 countsByYear W31346059732020 @default.
• W3134605973 countsByYear W31346059732021 @default.
• W3134605973 countsByYear W31346059732022 @default.
• W3134605973 crossrefType "posted-content" @default.
• W3134605973 hasAuthorship W3134605973A5002785674 @default.
• W3134605973 hasAuthorship W3134605973A5020529918 @default.
• W3134605973 hasAuthorship W3134605973A5022162844 @default.
• W3134605973 hasAuthorship W3134605973A5022470629 @default.
• W3134605973 hasAuthorship W3134605973A5034596312 @default.
• W3134605973 hasAuthorship W3134605973A5038928062 @default.
• W3134605973 hasAuthorship W3134605973A5041538214 @default.
• W3134605973 hasAuthorship W3134605973A5053607742 @default.
• W3134605973 hasAuthorship W3134605973A5059482122 @default.
• W3134605973 hasAuthorship W3134605973A5062544882 @default.
• W3134605973 hasAuthorship W3134605973A5063864987 @default.
• W3134605973 hasAuthorship W3134605973A5075596275 @default.
• W3134605973 hasAuthorship W3134605973A5076643205 @default.
• W3134605973 hasAuthorship W3134605973A5082620489 @default.
• W3134605973 hasBestOaLocation W31346059731 @default.
• W3134605973 hasConcept C14086860 @default.
• W3134605973 hasConcept C142724271 @default.
• W3134605973 hasConcept C159047783 @default.
• W3134605973 hasConcept C159654299 @default.

• next